Clinical and Angiographic Predictors of ST-Segment Recovery After Primary Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 105, Issue 12, 2010, Pages 1692-1697

  Verouden, Niels J W ^a   Haeck, Joost D E ^a   Kuijt, Wichert J ^a   Meuwissen, Martijn ^a   Koch, Karel T ^a   Henriques, José P S ^a   Baan, Jan ^a   Vis, Marije M ^a   Piek, Jan J ^a   Tijssen, Jan G P ^a   de Winter, Robbert J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; AORTA BALLOON; ARTICLE; BLOOD CLOT LYSIS; CONVALESCENCE; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SMOKING; ST SEGMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES;

EID: 77953120603     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.343     Document Type: Article

References (22)

1. Grines C.L., Browne K.F., Marco J., Rothbaum D., Stone G.W., O'Keefe J., Overlie P., Donohue B., Chelliah N., and Timmis G.C. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 328 (1993) 673-679
2. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
3. Gerber B.L., Rochitte C.E., Melin J.A., McVeigh E.R., Bluemke D.A., Wu K.C., Becker L.C., and Lima J.A. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 101 (2000) 2734-2741
4. Nijveldt R., Beek A.M., Hirsch A., Stoel M.G., Hofman M.B., Umans V.A., Algra P.R., Twisk J.W., and van Rossum A.C. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 52 (2008) 181-189
5. Brodie B.R., Stuckey T.D., Hansen C., VerSteeg D.S., Muncy D.B., Moore S., Gupta N., and Downey W.E. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 95 (2005) 343-348
6. Buller C.E., Fu Y., Mahaffey K.W., Todaro T.G., Adams P., Westerhout C.M., White H.D., van 't Hof A.W., Van de Werf F.J., Wagner G.S., Granger C.B., and Armstrong P.W. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation 118 (2008) 1335-1346
7. McLaughlin M.G., Stone G.W., Aymong E., Gardner G., Mehran R., Lansky A.J., Grines C.L., Tcheng J.E., Cox D.A., Stuckey T., Garcia E., Guagliumi G., Turco M., Josephson M.E., and Zimetbaum P. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 44 (2004) 1215-1223
8. Van 't Hof A.W., Liem A., de Boer M.J., and Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet 350 (1997) 615-619
9. TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 312 (1985) 932-936
10. Barbash G.I., White H.D., Modan M., Diaz R., Hampton J.R., Heikkila J., Kristinsson A., Moulopoulos S., Paolasso E.A., and Van der Werf T. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 87 (1993) 53-58
11. Fonarow G.C., Abraham W.T., Albert N.M., Stough W.G., Gheorghiade M., Greenberg B.H., O'Connor C.M., Nunez E., Yancy C.W., and Young J.B. A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF. Eur Heart J 29 (2008) 1983-1991
12. Albertal M., Cura F., Escudero A.G., Thierer J., Trivi M., Padilla L.T., and Belardi J. Mechanism involved in the paradoxical effects of active smoking following primary angioplasty: a subanalysis of the protection of distal embolization in high-risk patients with acute myocardial infarction trial. J Cardiovasc Med 9 (2008) 810-812
13. Danaei G., Lawes C.M., Vander H.S., Murray C.J., and Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 368 (2006) 1651-1659
14. Geiss L.S., Herman W.H., and Smith P.J. Mortality in Non-Insulin-Dependent Diabetes. Diabetes in America. 2nd Ed. (1995), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Bethesda 233-258
15. Donahoe S.M., Stewart G.C., McCabe C.H., Mohanavelu S., Murphy S.A., Cannon C.P., and Antman E.M. Diabetes and mortality following acute coronary syndromes. JAMA 298 (2007) 765-775
16. Van der Schaaf R.J., Timmer J.R., Ottervanger J.P., Hoorntje J.C., de Boer M.J., Suryapranata H., Zijlstra F., and Dambrink J.H. Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Heart 92 (2006) 1760-1763
17. Kandzari D.E., Hasselblad V., Tcheng J.E., Stone G.W., Califf R.M., Kastrati A., Neumann F.J., Brener S.J., Montalescot G., Kong D.F., and Harrington R.A. Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials. Am Heart J 147 (2004) 457-462
18. Kereiakes D.J., Berkowitz S.D., Lincoff A.M., Tcheng J.E., Wolski K., Achenbach R., Melsheimer R., Anderson K., Califf R.M., and Topol E.J. Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade. Am Heart J 140 (2000) 74-80
19. Montalescot G., Barragan P., Wittenberg O., Ecollan P., Elhadad S., Villain P., Boulenc J.M., Morice M.C., Maillard L., Pansieri M., Choussat R., and Pinton P. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344 (2001) 1895-1903
20. Eikelboom J.W., Mehta S.R., Anand S.S., Xie C., Fox K.A., and Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114 (2006) 774-782
21. De Luca G., Suryapranata H., Ottervanger J.P., Hoorntje J.C., Gosselink A.T., Dambrink J.H., de Boer M.J., and van 't Hof A.W. Postprocedural single-lead ST-segment deviation and long-term mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Heart 94 (2008) 44-47
22. Claeys M.J., Bosmans J., Veenstra L., Jorens P., De R., and Vrints C.J. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 99 (1999) 1972-1977